rs111231885

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004369.4(COL6A3):​c.4895G>A​(p.Arg1632Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00506 in 1,614,030 control chromosomes in the GnomAD database, including 144 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1632W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0057 ( 16 hom., cov: 32)
Exomes 𝑓: 0.0050 ( 128 hom. )

Consequence

COL6A3
NM_004369.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.909

Publications

12 publications found
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
COL6A3 Gene-Disease associations (from GenCC):
  • Bethlem myopathy 1A
    Inheritance: AD, SD, AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
  • Ullrich congenital muscular dystrophy 1C
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • collagen 6-related myopathy
    Inheritance: SD, AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • dystonia 27
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: ClinGen, Orphanet, Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AR, AD, SD Classification: STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004369.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003070861).
BP6
Variant 2-237368568-C-T is Benign according to our data. Variant chr2-237368568-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94941.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00569 (866/152174) while in subpopulation EAS AF = 0.0385 (199/5174). AF 95% confidence interval is 0.0341. There are 16 homozygotes in GnomAd4. There are 576 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR,AD,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004369.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A3
NM_004369.4
MANE Select
c.4895G>Ap.Arg1632Gln
missense
Exon 10 of 44NP_004360.2D9ZGF2
COL6A3
NM_057167.4
c.4277G>Ap.Arg1426Gln
missense
Exon 9 of 43NP_476508.2P12111-2
COL6A3
NM_057166.5
c.3074G>Ap.Arg1025Gln
missense
Exon 7 of 41NP_476507.3P12111-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A3
ENST00000295550.9
TSL:1 MANE Select
c.4895G>Ap.Arg1632Gln
missense
Exon 10 of 44ENSP00000295550.4P12111-1
COL6A3
ENST00000472056.5
TSL:1
c.3074G>Ap.Arg1025Gln
missense
Exon 7 of 41ENSP00000418285.1P12111-4
COL6A3
ENST00000353578.9
TSL:5
c.4277G>Ap.Arg1426Gln
missense
Exon 9 of 43ENSP00000315873.4P12111-2

Frequencies

GnomAD3 genomes
AF:
0.00571
AC:
868
AN:
152058
Hom.:
16
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.0386
Gnomad SAS
AF:
0.0309
Gnomad FIN
AF:
0.0340
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00156
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.0101
AC:
2537
AN:
251206
AF XY:
0.0113
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.000838
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.0360
Gnomad FIN exome
AF:
0.0286
Gnomad NFE exome
AF:
0.00196
Gnomad OTH exome
AF:
0.00750
GnomAD4 exome
AF:
0.00499
AC:
7296
AN:
1461856
Hom.:
128
Cov.:
33
AF XY:
0.00572
AC XY:
4163
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.000783
AC:
35
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00103
AC:
27
AN:
26136
East Asian (EAS)
AF:
0.0371
AC:
1472
AN:
39698
South Asian (SAS)
AF:
0.0284
AC:
2452
AN:
86252
European-Finnish (FIN)
AF:
0.0266
AC:
1420
AN:
53420
Middle Eastern (MID)
AF:
0.00954
AC:
55
AN:
5768
European-Non Finnish (NFE)
AF:
0.00119
AC:
1326
AN:
1111982
Other (OTH)
AF:
0.00813
AC:
491
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
389
778
1167
1556
1945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00569
AC:
866
AN:
152174
Hom.:
16
Cov.:
32
AF XY:
0.00774
AC XY:
576
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41512
American (AMR)
AF:
0.00111
AC:
17
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.0385
AC:
199
AN:
5174
South Asian (SAS)
AF:
0.0310
AC:
149
AN:
4812
European-Finnish (FIN)
AF:
0.0340
AC:
361
AN:
10604
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00156
AC:
106
AN:
67994
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00307
Hom.:
14
Bravo
AF:
0.00272
Asia WGS
AF:
0.0500
AC:
174
AN:
3478
EpiCase
AF:
0.00196
EpiControl
AF:
0.00124

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
not provided (2)
-
-
1
Bethlem myopathy 1A (1)
-
-
1
Collagen 6-related myopathy (1)
-
-
1
Ullrich congenital muscular dystrophy 1A;C4225336:Dystonia 27;CN029274:Bethlem myopathy 1A (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
7.4
DANN
Benign
0.68
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.97
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.044
N
LIST_S2
Benign
0.82
T
MetaRNN
Benign
0.0031
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.6
L
PhyloP100
-0.91
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.42
N
REVEL
Benign
0.14
Sift
Benign
0.30
T
Sift4G
Benign
0.14
T
Varity_R
0.045
gMVP
0.27
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs111231885;
hg19: chr2-238277211;
COSMIC: COSV55094155;
COSMIC: COSV55094155;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.